A Study to Determine the Safety and Immunogenicity of Bivalent GI.1 and GII.4 Vaccines in Healthy Volunteers
Study sponsor: Vaxart
Primary completion is the date data collection ends for the main study measures, not when results are published.
Primary completion2023-10-16Actual
Enrollment · participants135Actual
Source updated2025-04-15Last update listed in the registry record
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.